Benzoxazine derivatives as inhibitors of leukotrienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544 63, 544 92, 544 93, 544 94, 544105, A61K 31535, C07D26514, C07D26536

Patent

active

052179699

ABSTRACT:
The invention concerns a bicyclic heterocyclic compound of the formula I ##STR1## wherein Q is an optionally substituted 10-membered bicyclic heterocyclic moiety containing 1 or 2 N's and a further O or S heteroatom;

REFERENCES:
patent: 3661917 (1972-05-01), Kaiser et al.
patent: 3743737 (1973-07-01), Kaiser et al.
patent: 4567184 (1986-01-01), Musser et al.
patent: 4625034 (1986-11-01), Neiss et al.
patent: 4631287 (1986-12-01), Chakraborty et al.
patent: 4725619 (1916-02-01), Chakraborty et al.
patent: 4728668 (1988-03-01), Chakraborty et al.
patent: 4794188 (1988-12-01), Musser et al.
patent: 4839369 (1989-06-01), Youssefyeh et al.
patent: 4876346 (1989-10-01), Musser et al.
patent: 4918081 (1990-04-01), Huang et al.
patent: 4920130 (1990-04-01), Huang et al.
patent: 4920131 (1990-04-01), Huang et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 4920133 (1990-04-01), Huang et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzoxazine derivatives as inhibitors of leukotrienes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzoxazine derivatives as inhibitors of leukotrienes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazine derivatives as inhibitors of leukotrienes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1934212

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.